Patents by Inventor Roderick Phillips

Roderick Phillips has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pirfenidone/Toll-Like Receptor (TLR) Agonist Compounds and Methods of Treating Neutropenia
    Publication number: 20110218169
    Abstract: The invention disclosed herein relates to compositions and methods for treating subjects suffering from or at risk of developing neutropenia. In some embodiments, the methods comprise administering to a subject suffering from or at risk of developing neutropenia, an effective amount of pirfenidone and one or more toll-like receptor (TLR) agonists.
    Type: Application
    Filed: February 10, 2011
    Publication date: September 8, 2011
    Applicant: INTERMUNE, INC.
    Inventors: Roderick Phillips, Lawrence M. Blatt
  • PIRFENIDONE/TOLL-LIKE RECEPTOR (TLR) AGONIST COMPOSITIONS AND METHODS FOR USING THEM TO STIMULATE PRODUCTION OF GRANULOCYTE COLONIZING STIMULATING FACTOR (G-CSF)
    Publication number: 20090170804
    Abstract: The invention disclosed herein relates to compositions and methods for treating subjects suffering from or at risk of developing neutropenia. In some embodiments, the methods comprise administering to a subject suffering from or at risk of developing neutropenia, an effective amount of pirfenidone and one or more toll-like receptor (TLR) agonists.
    Type: Application
    Filed: October 30, 2006
    Publication date: July 2, 2009
    Inventors: Roderick Phillips, Lawrence M. Blatt
  • Non-natural chemokine receptor ligands and methods of use thereof
    Publication number: 20090131312
    Abstract: The present invention provides non-natural CXCR3 ligands comprising the N-loop region of the iTAC and polynucleotide encoding such non-natural CXCR3 ligands. The invention additionally provides methods of treating fÊbrotic disorders, angiogenic disorders, and cancer. The methods generally involve administering to an individual in need thereof an effective amount of a non-natural CXCR3 ligand of the invention.
    Type: Application
    Filed: May 17, 2006
    Publication date: May 21, 2009
    Inventors: Lawrence Blatt, Scott Seiwert, Hua Tan, Roderick Phillips